Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06503861 · ClinicalTrials.gov registry record · NA
Community-designed Food Is Medicine for Adults With Diabetes
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT06503861: Completed NA study, sponsored by Indiana University.
NCT06503861 is a NA study that has completed, run by Indiana University. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06503861, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if an educational intervention can affect clinical outcomes in adults with diabetes. The main question it aims to answer is: Can a Food Is Medicine intervention affect obesity and/or diabetes markers in adults? Researchers will compare a Food Is Medicine arm to a control arm to answer the research question. Participants will provide biometrics and questionnaire responses at three time points. Those in the Food Is Medicine arm will receive regular free meal kits combined with cooking and nutritional education.
Primary Outcome
Participants' glycated hemoglobin - Hemoglobin A1c (HbA1c)
Interventions
- BEHAVIORAL Food Is Medicine intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2021-09-12 |
| Phase | NA |
What the finished NCT06503861 record still lists
NCT06503861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Food Is Medicine intervention is the first listed.
NCT06503861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06503861 about?
NCT06503861 is a clinical study titled "Community-designed Food Is Medicine for Adults With Diabetes". The goal of this clinical trial is to learn if an educational intervention can affect clinical outcomes in adults with diabetes. The main question it aims to answer is: Can a Food Is Medicine intervention affect obesity and/or diabetes markers in adults? Researchers will compare a Food Is Medicine...
What is the current status of trial NCT06503861?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2020-06-15. Estimated completion is 2021-09-12.
What interventions are being tested in trial NCT06503861?
The interventions under investigation include: Food Is Medicine intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06503861?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06503861's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI